← All organizations

Aptose Biosciences Inc.

For profitWebsite ↗

Also known as: Aptose Biosciences Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 6, 2020

Timeline

1980s

Jun 1, 1986
Aptose Biosciences Inc.— Founded

Drugs by trial phase (4 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

ox bile extract

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

apto-253

Indications

Studied for

Recent trials (9)

NCT04477291Study directorPhase 1/Phase 2Oct 6, 2020
NCT04477291Lead sponsorPhase 1/Phase 2Oct 6, 2020
NCT03893682Study directorPhase 1Apr 30, 2019
NCT03893682Lead sponsorPhase 1Apr 30, 2019
NCT02267863Lead sponsorPhase 1Oct 1, 2014
NCT01281592Lead sponsorPhase 1Jan 1, 2011
NCT00565058Lead sponsorPhase 2Aug 1, 2007
NCT00040092Lead sponsorPhase 3Jul 1, 2002
NCT00056173Lead sponsorPhase 1/Phase 2Mar 1, 2002

Details

Founded: Toronto, ON, CA Jun 1, 1986
Last known activity: Oct 6, 2020